In this study, we verified that the expression level of miR-338-3p in osteosarcoma cell lines and tissues was downregulated and found that miR-338-3p suppressed the development and metastasis of osteosarcoma by targeting NRCAM directly. The gene discussed is NRCAM; the disease is osteosarcoma.